Manufacturer
Sanofi-Aventis
Contents
Hydrocortisone 0.5%, cinchocaine HCl 0.5%, framycetin sulfate 1%, aesculin 1%
Indication
Internal & external haemorrhoids; prophylaxis between attacks to prevent recurrences; haemorrhoidal complications eg, anal pruritus, perianal eczema, proctitis, fissure; pre-op & post-op treatment of haemorrhoidectomy patients; post-partum haemorrhoidal conditions.
Instruction
1 application of ointment twice daily and after defecation
Drug interaction
-
Malaysia
